Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Disruption of MAGI2-RapGEF2-Rap1 signaling contributes to podocyte dysfunction in congenital nephrotic syndrome caused by mutations in MAGI2.

Zhu B, Cao A, Li J, Young J, Wong J, Ashraf S, Bierzynska A, Menon MC, Hou S, Sawyers C, Campbell KN, Saleem MA, He JC, Hildebrandt F, D'Agati VD, Peng W, Kaufman L.

Kidney Int. 2019 Mar 28. pii: S0085-2538(19)30341-2. doi: 10.1016/j.kint.2019.03.016. [Epub ahead of print]

PMID:
31171376
2.

Assessment of ICD-10-CM code assignment validity for case finding of outpatient anticoagulant-related bleeding among Medicare beneficiaries.

Shehab N, Ziemba R, Campbell KN, Geller AI, Moro RN, Gage BF, Budnitz DS, Yang TH.

Pharmacoepidemiol Drug Saf. 2019 May 29. doi: 10.1002/pds.4783. [Epub ahead of print]

PMID:
31144403
3.

Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity.

Calizo RC, Bhattacharya S, van Hasselt JGC, Wei C, Wong JS, Wiener RJ, Ge X, Wong NJ, Lee JJ, Cuttitta CM, Jayaraman G, Au VH, Janssen W, Liu T, Li H, Salem F, Jaimes EA, Murphy B, Campbell KN, Azeloglu EU.

Nat Commun. 2019 May 3;10(1):2061. doi: 10.1038/s41467-019-09936-x.

4.

Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap.

Lee YA, Noon LA, Akat KM, Ybanez MD, Lee TF, Berres ML, Fujiwara N, Goossens N, Chou HI, Parvin-Nejad FP, Khambu B, Kramer EGM, Gordon R, Pfleger C, Germain D, John GR, Campbell KN, Yue Z, Yin XM, Cuervo AM, Czaja MJ, Fiel MI, Hoshida Y, Friedman SL.

Nat Commun. 2018 Nov 23;9(1):4962. doi: 10.1038/s41467-018-07338-z.

5.

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS.

Trachtman H, Nelson P, Adler S, Campbell KN, Chaudhuri A, Derebail VK, Gambaro G, Gesualdo L, Gipson DS, Hogan J, Lieberman K, Marder B, Meyers KE, Mustafa E, Radhakrishnan J, Srivastava T, Stepanians M, Tesar V, Zhdanova O, Komers R; DUET Study Group.

J Am Soc Nephrol. 2018 Nov;29(11):2745-2754. doi: 10.1681/ASN.2018010091.

PMID:
30361325
6.

SHROOM3-FYN Interaction Regulates Nephrin Phosphorylation and Affects Albuminuria in Allografts.

Wei C, Banu K, Garzon F, Basgen JM, Philippe N, Yi Z, Liu R, Choudhuri J, Fribourg M, Liu T, Cumpelik A, Wong J, Khan M, Das B, Keung K, Salem F, Campbell KN, Kaufman L, Cravedi P, Zhang W, O'Connell PJ, He JC, Murphy B, Menon MC.

J Am Soc Nephrol. 2018 Nov;29(11):2641-2657. doi: 10.1681/ASN.2018060573. Epub 2018 Oct 19.

PMID:
30341149
7.

Therapy for Proliferative Lupus Nephritis.

Meliambro K, Campbell KN, Chung M.

Rheum Dis Clin North Am. 2018 Nov;44(4):545-560. doi: 10.1016/j.rdc.2018.06.002. Epub 2018 Sep 7. Review.

PMID:
30274622
8.

Proteinuria in Nephrotic Syndrome: Mechanistic and Clinical Considerations in Optimizing Management.

Tumlin JA, Campbell KN.

Am J Nephrol. 2018;47 Suppl 1:1-2. doi: 10.1159/000481632. Epub 2018 May 31. No abstract available.

9.

Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.

Campbell KN, Tumlin JA.

Am J Nephrol. 2018;47 Suppl 1:14-29. doi: 10.1159/000481634. Epub 2018 May 31.

10.

Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis.

Wen Y, Shah S, Campbell KN.

Front Med (Lausanne). 2018 Apr 16;5:98. doi: 10.3389/fmed.2018.00098. eCollection 2018. Review.

11.

Hippo pathway deficiency and recovery from heart failure after myocardial infarction: potential implications for kidney disease.

Meliambro K, Campbell KN.

Kidney Int. 2018 Feb;93(2):290-292. doi: 10.1016/j.kint.2017.12.001. No abstract available.

PMID:
29389390
12.

A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis.

Vincenti F, Fervenza FC, Campbell KN, Diaz M, Gesualdo L, Nelson P, Praga M, Radhakrishnan J, Sellin L, Singh A, Thornley-Brown D, Veronese FV, Accomando B, Engstrand S, Ledbetter S, Lin J, Neylan J, Tumlin J; Focal Segmental Glomerulosclerosis Study Group.

Kidney Int Rep. 2017 Apr 7;2(5):800-810. doi: 10.1016/j.ekir.2017.03.011. eCollection 2017 Sep.

13.

The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.

Meliambro K, Wong JS, Ray J, Calizo RC, Towne S, Cole B, El Salem F, Gordon RE, Kaufman L, He JC, Azeloglu EU, Campbell KN.

J Biol Chem. 2017 Dec 22;292(51):21137-21148. doi: 10.1074/jbc.M117.819029. Epub 2017 Oct 5.

14.

Resizing Nephrology Training Programs: A Call to Action.

Melamed ML, Campbell KN, Nickolas TL.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1718-1720. doi: 10.2215/CJN.04740517. Epub 2017 Aug 24. No abstract available.

15.

Revisiting the determinants of the glomerular filtration barrier: what goes round must come round.

Schlöndorff D, Wyatt CM, Campbell KN.

Kidney Int. 2017 Sep;92(3):533-536. doi: 10.1016/j.kint.2017.06.003.

PMID:
28807257
16.

Complement in Non-Antibody-Mediated Kidney Diseases.

Angeletti A, Reyes-Bahamonde J, Cravedi P, Campbell KN.

Front Med (Lausanne). 2017 Jul 12;4:99. doi: 10.3389/fmed.2017.00099. eCollection 2017. Review.

17.

Glomerulosclerosis Induced by Deficiency of Membrane-Associated Guanylate Kinase Inverted 2 in Kidney Podocytes.

Shirata N, Ihara KI, Yamamoto-Nonaka K, Seki T, Makino SI, Oliva Trejo JA, Miyake T, Yamada H, Campbell KN, Nakagawa T, Mori K, Yanagita M, Mundel P, Nishimori K, Asanuma K.

J Am Soc Nephrol. 2017 Sep;28(9):2654-2669. doi: 10.1681/ASN.2016121356. Epub 2017 May 24.

18.

History, Passion, and Performance.

Campbell KN.

Workplace Health Saf. 2017 Apr;65(4):164-167. doi: 10.1177/2165079917700904.

PMID:
28414624
19.

Chronic kidney disease and risk factor prevalence in Saint Kitts and Nevis: a cross-sectional study.

Crews DC, Campbell KN, Liu Y, Bussue O, Dawkins I, Young BA.

BMC Nephrol. 2017 Jan 5;18(1):7. doi: 10.1186/s12882-016-0424-2.

20.

MAGI-1 Interacts with Nephrin to Maintain Slit Diaphragm Structure through Enhanced Rap1 Activation in Podocytes.

Ni J, Bao S, Johnson RI, Zhu B, Li J, Vadaparampil J, Smith CM, Campbell KN, Grahammer F, Huber TB, He JC, D'Agati VD, Chan A, Kaufman L.

J Biol Chem. 2016 Nov 18;291(47):24406-24417. Epub 2016 Oct 5.

Supplemental Content

Loading ...
Support Center